Moore Capital Management LP Sells 379,128 Shares of Teladoc Health, Inc. $TDOC

Moore Capital Management LP trimmed its stake in Teladoc Health, Inc. (NYSE:TDOC) by 93.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 27,503 shares of the health services provider’s stock after selling 379,128 shares during the period. Moore Capital Management LP’s holdings in Teladoc Health were worth $233,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Monaco Asset Management SAM purchased a new stake in Teladoc Health during the 2nd quarter valued at $26,864,000. Jupiter Asset Management Ltd. increased its position in Teladoc Health by 293.9% during the fourth quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider’s stock valued at $27,021,000 after acquiring an additional 2,880,008 shares during the last quarter. Quantinno Capital Management LP increased its position in Teladoc Health by 128.0% during the first quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock valued at $14,287,000 after acquiring an additional 1,471,631 shares during the last quarter. Pale Fire Capital SE raised its stake in shares of Teladoc Health by 74.8% in the first quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider’s stock valued at $18,522,000 after acquiring an additional 1,454,288 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in shares of Teladoc Health by 23.8% in the third quarter. Dimensional Fund Advisors LP now owns 6,889,194 shares of the health services provider’s stock valued at $53,260,000 after acquiring an additional 1,325,106 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Canaccord Genuity Group reduced their price objective on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. Bank of America raised their price objective on shares of Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a research note on Tuesday, July 7th. Finally, Citigroup decreased their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a research note on Monday, August 3rd. Five analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $7.54.

Teladoc Health Price Performance

TDOC stock opened at $6.25 on Wednesday. The company has a market capitalization of $1.14 billion, a PE ratio of -6.31 and a beta of 2.12. Teladoc Health, Inc. has a 12 month low of $4.40 and a 12 month high of $9.89. The firm’s 50-day moving average is $7.89 and its 200 day moving average is $6.67.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.04. The company had revenue of $606.93 million during the quarter, compared to analysts’ expectations of $615.44 million. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The firm’s quarterly revenue was down 4.0% on a year-over-year basis. During the same period in the previous year, the company earned ($0.19) EPS. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. Sell-side analysts forecast that Teladoc Health, Inc. will post -0.89 EPS for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.